TEAM-ICU: Effect of Positive Attitudes on Behavior and Wellness

Sponsor
Cedars-Sinai Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT04441632
Collaborator
(none)
24
1
1
1.5
16.2

Study Details

Study Description

Brief Summary

The COVID-19 pandemic has undoubtedly elevated levels of stress to people all over the globe, but none more than to the providers on the front-line. The purpose of the study is to first, assess the effects of the pandemic on burnout, team cohesion, and resiliency among healthcare providers battling COVID-19 together in a medical ICU (MICU). Secondly, the investigators hope to then assess the effects of simple positive feedback on transforming culture and attitudes during times of major stress.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Positive feedback
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
24 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Impact of Positive Reinforcement on Teamwork Climate, Resiliency, and Burnout During the COVID-19 Pandemic: the TEAM-ICU Study (Transforming Employee Attitudes Via Messaging Strengthens Interconnection, Communication, and Unity)
Actual Study Start Date :
Jun 15, 2020
Actual Primary Completion Date :
Jul 26, 2020
Actual Study Completion Date :
Jul 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Other: Positive feedback

Participants in the study will provide consistent positive feedback to the colleagues they work with in the medical ICU (MICU) over a 4 week duration.

Behavioral: Positive feedback
Participants will submit positive feedback comments to their colleagues (anonymously or signed, participant-dependent) through an anonymous survey link, a minimum of twice weekly to 6 uniquely different individuals over a 4 week period (total minimum 24 unique individuals over the study period).

Outcome Measures

Primary Outcome Measures

  1. Teamwork climate, as measured by selected items from the validated Safety Attitude Questionnaire (SAQ) [4 weeks]

    The SAQ measures teamwork climate, safety climate, job satisfaction, stress recognition, perceptions of management, and working conditions. The six items assessing teamwork climate will be used. 5 point likert scale is used. Mean of the items - 1 * 25 will convert each participant's results to a 100 point scale (0, 25, 50, 75, 100 points).

  2. Resiliency, as measured by the validated Brief Resilience Scale (BRS) [4 weeks]

    The BRS is comprised of 6 items on a likert scale. Responses varying from 1-5 for all six items give a total range of 6-30. This sum will be divided by the total number of questions for a final score.

  3. Burnout, as validated by the single-item burnout scale inventory [4 weeks]

    This single item inventory provides 5 definitions of burnout that the participant will choose that most closely fits their personal level of burnout at the moment

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Front-line healthcare providers in the Medical Intensive Care Unit (MICU): nurses, respiratory therapists, resident physicians, fellow physicians, and attending physicians
Exclusion Criteria:
  • Healthcare providers providing only consultatory care in the MICU

  • Front-line healthcare providers not working in the MICU during the study period

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cedars-Sinai Medical Center Los Angeles California United States 90048

Sponsors and Collaborators

  • Cedars-Sinai Medical Center

Investigators

  • Principal Investigator: Jack Green, MD, Cedars-Sinai Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jack Green, Assistant Professor of Pediatrics, Cedars-Sinai Medical Center
ClinicalTrials.gov Identifier:
NCT04441632
Other Study ID Numbers:
  • STUDY00000786
First Posted:
Jun 22, 2020
Last Update Posted:
Aug 12, 2020
Last Verified:
Aug 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jack Green, Assistant Professor of Pediatrics, Cedars-Sinai Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 12, 2020